MNRR1 is a driver of ovarian cancer progression
Cancer progression requires the acquisition of mechanisms that support proliferative potential and metastatic capacity. MNRR1 (also CHCHD2, PARK22, AAG10) is a bi-organellar protein that in the mitochondria can bind to Bcl-xL to enhance its anti-apoptotic function, or to respiratory chain complex IV...
| Published in: | Translational Oncology |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523323000086 |
